Serilón
Vasopressin antagonist indicated for the treatment of autosomal dominant polycystic kidney disease (ADPKD).
Therapeutic Area
Nephrology
Active Ingredient
Tolvaptan
Line
Specials
Dosage forms:
30 tablets containing 15 mg
28 tablets containing 30 mg
